During the Q2, we also repurchased 1,300,000 shares of our common stock at an aggregate purchase price of $20,100,000 increasing the total share repurchases during 2024 to 4,000,000 shares at an aggregate purchase price of $59,500,000 On May 16, 2024, our Board of Directors authorized an increase to the share repurchase program up to an additional $125,000,000 increasing the total authorization to 350,000,000 dollars Since our share repurchase program was announced in May 2022 through June 30, we have repurchased 14,100,000 shares of our stock at a total cost of $172,100,000 or an average price of $12.20 per share, leaving $177,900,000 available under the Board authorization. As of June 30, we had $60,000,000 of cash on hand and additional $232,000,000 of borrowing capacity on our revolving credit facility, providing us with total liquidity of $292,000,000 Our leverage measured by net debt to adjusted EBITDA was 2.5 times using the trailing 12 months ended June 30, 2024, down from 3.1 times at June 30, 2023 and within our targeted leverage of between 2.25 times and 2.75 times. Moving lastly to a discussion of our 2024 financial guidance. We expect to generate adjusted EPS of $0.58 to $0.66 and normalized FFO per share of $1.48 to $1.56 We expect federal populations to remain within a stable range for the remainder of 2024.